GDS Stock Overview
Operates healthcare facilities in France, Sweden, Norway, Denmark, and Italy. More details
| Snowflake Score | |
|---|---|
| Valuation | 4/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 2/6 |
| Dividends | 0/6 |
My Notes
Capture your thoughts, links and company narrative
Ramsay Générale de Santé SA Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | €11.45 |
| 52 Week High | €19.90 |
| 52 Week Low | €11.00 |
| Beta | 0.22 |
| 1 Month Change | -0.87% |
| 3 Month Change | -21.31% |
| 1 Year Change | -38.11% |
| 3 Year Change | -44.95% |
| 5 Year Change | -32.65% |
| Change since IPO | 6,442.86% |
Recent News & Updates
We Think Ramsay Générale de Santé SA's (EPA:GDS) CEO Compensation Package Needs To Be Put Under A Microscope
Dec 06
Is Ramsay Générale de Santé (EPA:GDS) Using Too Much Debt?
Oct 28Ramsay Générale de Santé SA (EPA:GDS) Could Be Riskier Than It Looks
Oct 02Recent updates
We Think Ramsay Générale de Santé SA's (EPA:GDS) CEO Compensation Package Needs To Be Put Under A Microscope
Dec 06Is Ramsay Générale de Santé (EPA:GDS) Using Too Much Debt?
Oct 28Ramsay Générale de Santé SA (EPA:GDS) Could Be Riskier Than It Looks
Oct 02Returns On Capital At Ramsay Générale de Santé (EPA:GDS) Paint A Concerning Picture
May 29Many Still Looking Away From Ramsay Générale de Santé SA (EPA:GDS)
May 03Ramsay Générale de Santé (EPA:GDS) Seems To Be Using A Lot Of Debt
Mar 29Investors Interested In Ramsay Générale de Santé SA's (EPA:GDS) Earnings
Jan 23Ramsay Générale de Santé (EPA:GDS) Has A Somewhat Strained Balance Sheet
Oct 26Ramsay Générale de Santé (EPA:GDS) Is Reinvesting At Lower Rates Of Return
Oct 05Does Ramsay Générale de Santé (EPA:GDS) Deserve A Spot On Your Watchlist?
Aug 09We Think Ramsay Générale de Santé (EPA:GDS) Is Taking Some Risk With Its Debt
Jun 16The Returns At Ramsay Générale de Santé (EPA:GDS) Aren't Growing
May 27Is Now The Time To Put Ramsay Générale de Santé (EPA:GDS) On Your Watchlist?
May 06Is Ramsay Générale de Santé (EPA:GDS) Using Too Much Debt?
Mar 15Returns On Capital At Ramsay Générale de Santé (EPA:GDS) Have Stalled
Feb 23Does Ramsay Générale de Santé (EPA:GDS) Deserve A Spot On Your Watchlist?
Jan 03Slowing Rates Of Return At Ramsay Générale de Santé (EPA:GDS) Leave Little Room For Excitement
Nov 19Here's Why We Think Ramsay Générale de Santé (EPA:GDS) Is Well Worth Watching
Sep 13Ramsay Générale de Santé (EPA:GDS) Has Some Way To Go To Become A Multi-Bagger
Aug 09Here's Why I Think Ramsay Générale de Santé (EPA:GDS) Is An Interesting Stock
Jun 02Return Trends At Ramsay Générale de Santé (EPA:GDS) Aren't Appealing
Mar 29If You Like EPS Growth Then Check Out Ramsay Générale de Santé (EPA:GDS) Before It's Too Late
Feb 01Slowing Rates Of Return At Ramsay Générale de Santé (EPA:GDS) Leave Little Room For Excitement
Dec 05Here's Why We Think Ramsay Générale de Santé (EPA:GDS) Is Well Worth Watching
Oct 30Is Ramsay Générale de Santé (EPA:GDS) A Risky Investment?
Oct 11Ramsay Générale de Santé (EPA:GDS) Will Want To Turn Around Its Return Trends
Aug 31If You Like EPS Growth Then Check Out Ramsay Générale de Santé (EPA:GDS) Before It's Too Late
Jul 15These 4 Measures Indicate That Ramsay Générale de Santé (EPA:GDS) Is Using Debt Extensively
Jun 15Ramsay Générale de Santé (EPA:GDS) Will Will Want To Turn Around Its Return Trends
May 04We Think Ramsay Générale de Santé (EPA:GDS) Is Taking Some Risk With Its Debt
Mar 08Should We Be Cautious About Ramsay Générale de Santé SA's (EPA:GDS) ROE Of 1.7%?
Feb 15Should We Be Excited About The Trends Of Returns At Ramsay Générale de Santé (EPA:GDS)?
Jan 19Should Ramsay Générale de Santé (EPA:GDS) Be Disappointed With Their 19% Profit?
Dec 23
Here's Why Ramsay Générale de Santé's (EPA:GDS) Statutory Earnings Are Arguably Too Conservative
Dec 03Shareholder Returns
| GDS | FR Healthcare | FR Market | |
|---|---|---|---|
| 7D | -0.4% | -1.9% | -1.1% |
| 1Y | -38.1% | -45.3% | -4.8% |
Return vs Industry: GDS exceeded the French Healthcare industry which returned -45.3% over the past year.
Return vs Market: GDS underperformed the French Market which returned -4.8% over the past year.
Price Volatility
| GDS volatility | |
|---|---|
| GDS Average Weekly Movement | 4.2% |
| Healthcare Industry Average Movement | 5.6% |
| Market Average Movement | 4.6% |
| 10% most volatile stocks in FR Market | 9.7% |
| 10% least volatile stocks in FR Market | 2.3% |
Stable Share Price: GDS has not had significant price volatility in the past 3 months compared to the French market.
Volatility Over Time: GDS's weekly volatility (4%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1987 | 34,218 | Pascal Roche | www.ramsaygds.fr |
Ramsay Générale de Santé SA operates healthcare facilities in France, Sweden, Norway, Denmark, and Italy. The company operates proximity care centers, and clinics and specialized hospitals; and provides primary medicine, medicine surgery obstetrics (MSO) dialysis, oncology, medical imaging, medical care, follow-up and rehabilitation care, home care and hospitalization, mental health care, and addiction treatment, telemedicine e health, elderly, emergency, maternity, nutrition, obesity and eating disorders, sanitary transport, outpatient surgery and eras, and SMR services. Ramsay Générale de Santé SA was formerly known as Générale de Santé SA and changed its name to Ramsay Générale de Santé SA in December 2015.
Ramsay Générale de Santé SA Fundamentals Summary
| GDS fundamental statistics | |
|---|---|
| Market cap | €1.26b |
| Earnings (TTM) | -€53.90m |
| Revenue (TTM) | €5.01b |
0.3x
P/S Ratio-23.4x
P/E RatioIs GDS overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| GDS income statement (TTM) | |
|---|---|
| Revenue | €5.01b |
| Cost of Revenue | €3.63b |
| Gross Profit | €1.37b |
| Other Expenses | €1.43b |
| Earnings | -€53.90m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.49 |
| Gross Margin | 27.40% |
| Net Profit Margin | -1.08% |
| Debt/Equity Ratio | 161.4% |
How did GDS perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/23 22:09 |
| End of Day Share Price | 2024/12/23 00:00 |
| Earnings | 2024/06/30 |
| Annual Earnings | 2024/06/30 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Ramsay Générale de Santé SA is covered by 4 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Frederic Caumon | Deutsche Bank |
| Murielle Andre-Pinard | HSBC |
| Cédric Moreau | Natixis S.A. |